Noninvasive assessment of liver fibrosis with the aspartate transaminase to platelet ratio index (APRI): Usefulness in patients with chronic liver disease


YILMAZ Y., Yonal O., Kurt R., Bayrak M., Aktas B., Ozdogan O.

HEPATITIS MONTHLY, vol.11, no.2, pp.103-107, 2011 (Peer-Reviewed Journal) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 11 Issue: 2
  • Publication Date: 2011
  • Journal Name: HEPATITIS MONTHLY
  • Journal Indexes: Science Citation Index Expanded, Scopus
  • Page Numbers: pp.103-107
  • Keywords: Chronic hepatitis C, Chronic hepatitis B, Fatty liver, Fibrosis, Aspartate aminotransferases, CHRONIC HEPATITIS-C, BLOOD-TESTS, PREDICT, CIRRHOSIS, BIOPSY, FIBROSCAN(R), COINFECTION, VALIDATION, INFECTION, DIAGNOSIS

Abstract

Background: The aspartate aminotransferases (AST) to platelet ratio index (APRI) may serve as a noninvasive marker to assess liver fibrosis.